"10.1371_journal.pone.0090325","plos one","2014-03-10T00:00:00Z","Arja Helin-Salmivaara; Piia Lavikainen; Emma Aarnio; Risto Huupponen; Maarit Jaana Korhonen","Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland; Unit of Primary Health Care, Hospital District of Helsinki and Uusimaa, Helsinki, Finland; Department of Clinical Pharmacology, Tykslab, Turku University Hospital, Turku, Finland; School of Pharmacy, University of Eastern Finland, Kuopio, Finland; Department of Public Health, University of Turku, Turku, Finland","Conceived and designed the experiments: AHS PL EA MK RH. Analyzed the data: AHS MK. Wrote the paper: AHS PL EA MK RH.","The authors have read the journal's policy and have the following conflicts: AHS, MK and RH have been funded by the grants from the Social Insurance Institution and the Academy of Finland. EA was supported by state funding for university-level health research (Grant L 3820). She has received consultancy fees from ESiOR Ltd, which provides health economic and outcomes research services for pharmaceutical companies and hospitals. RH is a member of the Advisory Board for Social and Medical Affairs of the SII. He has conducted consultancy for Orion Corporation as an Independent External Member of a Data Monitoring and Safety Committee in a clinical trial, and assisted Santen Pharmaceutical Co in pharmacokinetic calculations. The authors declare no other financial or non-financial (professional or personal) conflict of interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Arja Helin-Salmivaara","AHS",5,TRUE,5,NA,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
